Pharming Group NV (PHAR)

  • A brief financial summary of Pharming Group NV as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Select Exchange

Symbol Exchange Currency
PHAR Amsterdam EUR Real-time PHARMa BATS Europe EUR Delayed PHAR NASDAQ USD Real-time PHGN Frankfurt EUR Delayed
1.107 -0.027 (-2.38%)
Closed EUR Disclaimer

PHAR Financial Summary

Pharming Group N.V. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 42.54 million compared to USD 46.62 million a year ago. Net loss was USD 12.21 million compared to net income of USD 3.46 million a year ago. Basic loss per share from continuing operations was USD 0.019 compared to basic earnings per share from continuing operations of USD 0.005 a year ago. Diluted loss per share from continuing operations was USD 0.017 compared to diluted earnings per share from continuing operations of USD 0.005 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
PHAR Income Statement
PHAR
Gross margin TTM 91.68%
Operating margin TTM -3.04%
Net Profit margin TTM -0.99%
Return on Investment TTM -1.37%
Total Revenue
Net Income
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Total Revenue 42.54 54.62 54.24 50.15
Gross Profit 38.47 48.35 51.86 46.12
Operating Income -13.66 -18.04 20.47 5.11
Net Income -12.21 -14.63 9.10 15.74

Customize

Clear All
0Selected
Please try another search
PHAR Balance Sheet
PHAR
Quick Ratio MRQ 3.69
Current Ratio MRQ 4.51
LT Debt to Equity MRQ 67.01%
Total Debt to Equity MRQ 85.48%
Total Assets
Total Liabilities
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Total Assets 423 425.80 382.32 393.90
Total Liabilities 223.65 221.16 182.07 194.23
Total Equity 199.34 204.64 200.25 199.67

Customize

Clear All
0Selected
Please try another search
PHAR Cash Flow Statement
PHAR
Cash Flow/Share TTM 0
Revenue/Share TTM 0.31
Operating Cash Flow -38.61%
Cash
Net Change in Cash
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Cash From Operating Activities -22.78 5.24 12.62 4
Cash From Investing Activities -0.22 -0.40 -0.30 6.39
Cash From Financing Activities -2.63 0.28 -1.92 -0.45
Net Change in Cash -22.56 18.64 -1.26 0.29

Customize

Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.